Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

GWAS meta-analysis identifies genetic variants linked to vertigo

Nov. 2, 2021

Oxytocin receptor hypermethylation tied to obsessive-compulsive disorder

Oct. 26, 2021

AKAP11 identified as shared risk gene in bipolar disorder and schizophrenia

Oct. 26, 2021

ABHD16A deficiency linked to subtype of complicated hereditary spastic paraplegia

Oct. 25, 2021

Biallelic variants in the KARS1 gene tied to neurodevelopmental disorders and hearing loss

Oct. 25, 2021

Splice variant in DEGS1 leads to hypomyelinating leukodystrophy-like phenotype

Oct. 22, 2021

SLFN11 predicts treatment response to TAS-1553 in AML

Oct. 22, 2021

BUD13 identified as candidate gene in specific language impairment

Oct. 22, 2021

ARID1A is a marker of endometriosis progression

Oct. 22, 2021

HLA fine mapping identifies INPP5A as a risk gene for tuberculosis

Oct. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...